Menu
GeneBe

5-123090139-G-A

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001136239.4(PRDM6):c.125G>A(p.Gly42Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000241 in 1,534,414 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000026 ( 0 hom. )

Consequence

PRDM6
NM_001136239.4 missense

Scores

1
3
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.0720
Variant links:
Genes affected
PRDM6 (HGNC:9350): (PR/SET domain 6) The protein encoded by this gene is a transcriptional repressor and a member of the PRDM family. Family members contain a PR domain and multiple zinc-finger domains. The encoded protein is involved in regulation of vascular smooth muscle cells (VSMC) contractile proteins. Mutations in this gene result in patent ductus arteriosus 3 (PDA3). [provided by RefSeq, Apr 2017]
PRDM6-AS1 (HGNC:55869): (PRDM6 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.065745145).
BS2
High AC in GnomAdExome at 5 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PRDM6NM_001136239.4 linkuse as main transcriptc.125G>A p.Gly42Asp missense_variant 2/8 ENST00000407847.5
PRDM6-AS1NR_146771.1 linkuse as main transcriptn.178C>T non_coding_transcript_exon_variant 1/2
PRDM6XM_047417878.1 linkuse as main transcriptc.125G>A p.Gly42Asp missense_variant 2/4
PRDM6XR_001742346.2 linkuse as main transcriptn.419G>A non_coding_transcript_exon_variant 2/9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PRDM6ENST00000407847.5 linkuse as main transcriptc.125G>A p.Gly42Asp missense_variant 2/85 NM_001136239.4 P1Q9NQX0-3
PRDM6-AS1ENST00000458103.2 linkuse as main transcriptn.161C>T non_coding_transcript_exon_variant 1/22

Frequencies

GnomAD3 genomes
AF:
0.00000659
AC:
1
AN:
151850
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000401
AC:
5
AN:
124722
Hom.:
0
AF XY:
0.0000583
AC XY:
4
AN XY:
68584
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000867
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000937
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000235
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000260
AC:
36
AN:
1382564
Hom.:
0
Cov.:
42
AF XY:
0.0000293
AC XY:
20
AN XY:
682054
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000863
Gnomad4 ASJ exome
AF:
0.000122
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000767
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000205
Gnomad4 OTH exome
AF:
0.0000349
GnomAD4 genome
AF:
0.00000659
AC:
1
AN:
151850
Hom.:
0
Cov.:
33
AF XY:
0.00
AC XY:
0
AN XY:
74166
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000113

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsSep 07, 2022The c.125G>A (p.G42D) alteration is located in exon 2 (coding exon 1) of the PRDM6 gene. This alteration results from a G to A substitution at nucleotide position 125, causing the glycine (G) at amino acid position 42 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.33
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.61
Cadd
Benign
10
Dann
Benign
0.85
DEOGEN2
Benign
0.0040
T
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.059
N
LIST_S2
Benign
0.42
T
M_CAP
Uncertain
0.095
D
MetaRNN
Benign
0.066
T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
0.0
N
MutationTaster
Benign
1.0
N
PrimateAI
Pathogenic
0.89
D
PROVEAN
Benign
-0.62
N
REVEL
Benign
0.063
Sift
Uncertain
0.0020
D
Sift4G
Uncertain
0.028
D
Polyphen
0.062
B
Vest4
0.23
MutPred
0.12
Gain of relative solvent accessibility (P = 0.0479);
MVP
0.088
ClinPred
0.052
T
GERP RS
0.64
Varity_R
0.15
gMVP
0.14

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1010829654; hg19: chr5-122425834; API